To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02760797
Title A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA | BEL

Facility Status City State Zip Country Details
Memorial Sloan-Kettering Cancer Center New York New York United States Details
University Pennsylvania Hospital Philadelphia Pennsylvania 19104 United States Details
Cliniques Universitaires St-Luc Bruxelles 1200 Belgium Details
Centre Leon Berard; Departement Oncologie Medicale Lyon 69373 France Details
Institut Claudius Regaud; Departement Oncologie Medicale Toulouse 31059 France Details
Institut Gustave Roussy; Sitep VILLEJUIF Cedex 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field